• Regeneron Pharmaceuticals EPS for the quarter ending December 31, 2024 was $8.12, a 20.47% decline year-over-year.
• Regeneron Pharmaceuticals 2024 annual EPS was $38.34, a 10.27% increase from 2023.
• Regeneron Pharmaceuticals 2023 annual EPS was $34.77, a 9.03% decline from 2022.
• Regeneron Pharmaceuticals 2022 annual EPS was $38.22, a 46.89% decline from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.